Global Bartter Syndrome Drugs Market Growth (Status and Outlook) 2018-2023

October 2018 | 118 pages | ID: G7DBE5219D0EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function.

According to this study, over the next five years the Bartter Syndrome Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global revenue market share of key companies in Bartter Syndrome Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Bartter Syndrome Drugs market by product type, application, key companies and key regions.

This study considers the Bartter Syndrome Drugs value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 10.7.

• NSAIDs (Nonsteroidal Anti-inflammatory Drugs)
• RAAS Inhibitors
• Angiotensin II Receptor Blockers
• Angiotensin-Converting Enzyme (ACE) Inhibitors
• Others

Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 10.8.

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• Abbott Laboratories
• Novartis
• Pfizer
• Eli Lilly
• Bristol-Myers Squibb

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Bartter Syndrome Drugs market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Bartter Syndrome Drugs market by identifying its various subsegments.
• Focuses on the key global Bartter Syndrome Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Bartter Syndrome Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Bartter Syndrome Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Bartter Syndrome Drugs Market Size 2013-2023
  2.1.2 Bartter Syndrome Drugs Market Size CAGR by Region
2.2 Bartter Syndrome Drugs Segment by Type
  2.2.1 NSAIDs (Nonsteroidal Anti-inflammatory Drugs)
  2.2.2 RAAS Inhibitors
  2.2.3 Aldosterone Antagonists
  2.2.4 Angiotensin II Receptor Blockers
  2.2.5 Angiotensin-Converting Enzyme (ACE) Inhibitors
  2.2.6 Others
2.3 Bartter Syndrome Drugs Market Size by Type
  2.3.1 Global Bartter Syndrome Drugs Market Size Market Share by Type (2013-2018)
  2.3.2 Global Bartter Syndrome Drugs Market Size Growth Rate by Type (2013-2018)
2.4 Bartter Syndrome Drugs Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Bartter Syndrome Drugs Market Size by Application
  2.5.1 Global Bartter Syndrome Drugs Market Size Market Share by Application (2013-2018)
  2.5.2 Global Bartter Syndrome Drugs Market Size Growth Rate by Application (2013-2018)

3 GLOBAL BARTTER SYNDROME DRUGS BY PLAYERS

3.1 Global Bartter Syndrome Drugs Market Size Market Share by Players
  3.1.1 Global Bartter Syndrome Drugs Market Size by Players (2016-2018)
  3.1.2 Global Bartter Syndrome Drugs Market Size Market Share by Players (2016-2018)
3.2 Global Bartter Syndrome Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BARTTER SYNDROME DRUGS BY REGIONS

4.1 Bartter Syndrome Drugs Market Size by Regions
4.2 Americas Bartter Syndrome Drugs Market Size Growth
4.3 APAC Bartter Syndrome Drugs Market Size Growth
4.4 Europe Bartter Syndrome Drugs Market Size Growth
4.5 Middle East & Africa Bartter Syndrome Drugs Market Size Growth

5 AMERICAS

5.1 Americas Bartter Syndrome Drugs Market Size by Countries
5.2 Americas Bartter Syndrome Drugs Market Size by Type
5.3 Americas Bartter Syndrome Drugs Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Bartter Syndrome Drugs Market Size by Countries
6.2 APAC Bartter Syndrome Drugs Market Size by Type
6.3 APAC Bartter Syndrome Drugs Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Bartter Syndrome Drugs by Countries
7.2 Europe Bartter Syndrome Drugs Market Size by Type
7.3 Europe Bartter Syndrome Drugs Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Bartter Syndrome Drugs by Countries
8.2 Middle East & Africa Bartter Syndrome Drugs Market Size by Type
8.3 Middle East & Africa Bartter Syndrome Drugs Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL BARTTER SYNDROME DRUGS MARKET FORECAST

10.1 Global Bartter Syndrome Drugs Market Size Forecast (2018-2023)
10.2 Global Bartter Syndrome Drugs Forecast by Regions
  10.2.1 Global Bartter Syndrome Drugs Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Bartter Syndrome Drugs Forecast by Type
10.8 Global Bartter Syndrome Drugs Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Abbott Laboratories
  11.1.1 Company Details
  11.1.2 Bartter Syndrome Drugs Product Offered
  11.1.3 Abbott Laboratories Bartter Syndrome Drugs Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Abbott Laboratories News
11.2 Novartis
  11.2.1 Company Details
  11.2.2 Bartter Syndrome Drugs Product Offered
  11.2.3 Novartis Bartter Syndrome Drugs Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Novartis News
11.3 Pfizer
  11.3.1 Company Details
  11.3.2 Bartter Syndrome Drugs Product Offered
  11.3.3 Pfizer Bartter Syndrome Drugs Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Pfizer News
11.4 Eli Lilly
  11.4.1 Company Details
  11.4.2 Bartter Syndrome Drugs Product Offered
  11.4.3 Eli Lilly Bartter Syndrome Drugs Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Eli Lilly News
11.5 Bristol-Myers Squibb
  11.5.1 Company Details
  11.5.2 Bartter Syndrome Drugs Product Offered
  11.5.3 Bristol-Myers Squibb Bartter Syndrome Drugs Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Bristol-Myers Squibb News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Bartter Syndrome Drugs
Figure Bartter Syndrome Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Bartter Syndrome Drugs Market Size Growth Rate 2013-2023 ($ Millions)
Table Bartter Syndrome Drugs Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of NSAIDs (Nonsteroidal Anti-inflammatory Drugs)
Table Major Players of RAAS Inhibitors
Table Major Players of Aldosterone Antagonists
Table Major Players of Angiotensin II Receptor Blockers
Table Major Players of Angiotensin-Converting Enzyme (ACE) Inhibitors
Table Major Players of Others
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Bartter Syndrome Drugs Market Size Market Share by Type (2013-2018)
Figure Global Bartter Syndrome Drugs Market Size Market Share by Type (2013-2018)
Figure Global NSAIDs (Nonsteroidal Anti-inflammatory Drugs) Market Size Growth Rate
Figure Global RAAS Inhibitors Market Size Growth Rate
Figure Global Aldosterone Antagonists Market Size Growth Rate
Figure Global Angiotensin II Receptor Blockers Market Size Growth Rate
Figure Global Angiotensin-Converting Enzyme (ACE) Inhibitors Market Size Growth Rate
Figure Global Others Market Size Growth Rate
Figure Bartter Syndrome Drugs Consumed in Hospital Pharmacies
Figure Global Bartter Syndrome Drugs Market: Hospital Pharmacies (2013-2018) ($ Millions)
Figure Global Hospital Pharmacies YoY Growth ($ Millions)
Figure Bartter Syndrome Drugs Consumed in Retail Pharmacies
Figure Global Bartter Syndrome Drugs Market: Retail Pharmacies (2013-2018) ($ Millions)
Figure Global Retail Pharmacies YoY Growth ($ Millions)
Figure Bartter Syndrome Drugs Consumed in Online Pharmacies
Figure Global Bartter Syndrome Drugs Market: Online Pharmacies (2013-2018) ($ Millions)
Figure Global Online Pharmacies YoY Growth ($ Millions)
Table Global Bartter Syndrome Drugs Market Size by Application (2013-2018) ($ Millions)
Table Global Bartter Syndrome Drugs Market Size Market Share by Application (2013-2018)
Figure Global Bartter Syndrome Drugs Market Size Market Share by Application (2013-2018)
Figure Global Bartter Syndrome Drugs Market Size in Hospital Pharmacies Growth Rate
Figure Global Bartter Syndrome Drugs Market Size in Retail Pharmacies Growth Rate
Figure Global Bartter Syndrome Drugs Market Size in Online Pharmacies Growth Rate
Table Global Bartter Syndrome Drugs Revenue by Players (2016-2018) ($ Millions)
Table Global Bartter Syndrome Drugs Revenue Market Share by Players (2016-2018)
Figure Global Bartter Syndrome Drugs Revenue Market Share by Players in 2017
Table Global Bartter Syndrome Drugs Key Players Head office and Products Offered
Table Bartter Syndrome Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Bartter Syndrome Drugs Market Size by Regions 2013-2018 ($ Millions)
Table Global Bartter Syndrome Drugs Market Size Market Share by Regions 2013-2018
Figure Global Bartter Syndrome Drugs Market Size Market Share by Regions 2013-2018
Figure Americas Bartter Syndrome Drugs Market Size 2013-2018 ($ Millions)
Figure APAC Bartter Syndrome Drugs Market Size 2013-2018 ($ Millions)
Figure Europe Bartter Syndrome Drugs Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Bartter Syndrome Drugs Market Size 2013-2018 ($ Millions)
Table Americas Bartter Syndrome Drugs Market Size by Countries (2013-2018) ($ Millions)
Table Americas Bartter Syndrome Drugs Market Size Market Share by Countries (2013-2018)
Figure Americas Bartter Syndrome Drugs Market Size Market Share by Countries in 2017
Table Americas Bartter Syndrome Drugs Market Size by Type (2013-2018) ($ Millions)
Table Americas Bartter Syndrome Drugs Market Size Market Share by Type (2013-2018)
Figure Americas Bartter Syndrome Drugs Market Size Market Share by Type in 2017
Table Americas Bartter Syndrome Drugs Market Size by Application (2013-2018) ($ Millions)
Table Americas Bartter Syndrome Drugs Market Size Market Share by Application (2013-2018)
Figure Americas Bartter Syndrome Drugs Market Size Market Share by Application in 2017
Figure United States Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Canada Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Table APAC Bartter Syndrome Drugs Market Size by Countries (2013-2018) ($ Millions)
Table APAC Bartter Syndrome Drugs Market Size Market Share by Countries (2013-2018)
Figure APAC Bartter Syndrome Drugs Market Size Market Share by Countries in 2017
Table APAC Bartter Syndrome Drugs Market Size by Type (2013-2018) ($ Millions)
Table APAC Bartter Syndrome Drugs Market Size Market Share by Type (2013-2018)
Figure APAC Bartter Syndrome Drugs Market Size Market Share by Type in 2017
Table APAC Bartter Syndrome Drugs Market Size by Application (2013-2018) ($ Millions)
Table APAC Bartter Syndrome Drugs Market Size Market Share by Application (2013-2018)
Figure APAC Bartter Syndrome Drugs Market Size Market Share by Application in 2017
Figure China Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Japan Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Korea Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure India Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Australia Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Table Europe Bartter Syndrome Drugs Market Size by Countries (2013-2018) ($ Millions)
Table Europe Bartter Syndrome Drugs Market Size Market Share by Countries (2013-2018)
Figure Europe Bartter Syndrome Drugs Market Size Market Share by Countries in 2017
Table Europe Bartter Syndrome Drugs Market Size by Type (2013-2018) ($ Millions)
Table Europe Bartter Syndrome Drugs Market Size Market Share by Type (2013-2018)
Figure Europe Bartter Syndrome Drugs Market Size Market Share by Type in 2017
Table Europe Bartter Syndrome Drugs Market Size by Application (2013-2018) ($ Millions)
Table Europe Bartter Syndrome Drugs Market Size Market Share by Application (2013-2018)
Figure Europe Bartter Syndrome Drugs Market Size Market Share by Application in 2017
Figure Germany Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure France Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure UK Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Italy Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Russia Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Spain Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Bartter Syndrome Drugs Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Bartter Syndrome Drugs Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Bartter Syndrome Drugs Market Size Market Share by Countries in 2017
Table Middle East & Africa Bartter Syndrome Drugs Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Bartter Syndrome Drugs Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Bartter Syndrome Drugs Market Size Market Share by Type in 2017
Table Middle East & Africa Bartter Syndrome Drugs Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Bartter Syndrome Drugs Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Bartter Syndrome Drugs Market Size Market Share by Application in 2017
Figure Egypt Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Israel Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Bartter Syndrome Drugs Market Size Growth 2013-2018 ($ Millions)
Figure Global Bartter Syndrome Drugs arket Size Forecast (2018-2023) ($ Millions)
Table Global Bartter Syndrome Drugs Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Bartter Syndrome Drugs Market Size Market Share Forecast by Regions
Figure Americas Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure APAC Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Europe Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure United States Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Canada Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Mexico Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Brazil Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure China Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Japan Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Korea Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure India Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Australia Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Germany Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure France Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure UK Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Italy Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Russia Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Spain Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Egypt Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure South Africa Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Israel Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure Turkey Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Figure GCC Countries Bartter Syndrome Drugs Market Size 2018-2023 ($ Millions)
Table Global Bartter Syndrome Drugs Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Bartter Syndrome Drugs Market Size Market Share Forecast by Type (2018-2023)
Table Global Bartter Syndrome Drugs Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Bartter Syndrome Drugs Market Size Market Share Forecast by Application (2018-2023)
Table Abbott Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table Abbott Laboratories Bartter Syndrome Drugs Revenue and Gross Margin (2016-2018)
Figure Abbott Laboratories Bartter Syndrome Drugs Market Share (2016-2018)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Bartter Syndrome Drugs Revenue and Gross Margin (2016-2018)
Figure Novartis Bartter Syndrome Drugs Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Bartter Syndrome Drugs Revenue and Gross Margin (2016-2018)
Figure Pfizer Bartter Syndrome Drugs Market Share (2016-2018)
Table Eli Lilly Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lilly Bartter Syndrome Drugs Revenue and Gross Margin (2016-2018)
Figure Eli Lilly Bartter Syndrome Drugs Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb Bartter Syndrome Drugs Revenue and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Bartter Syndrome Drugs Market Share (2016-2018)